Monday November 23 2009 | Biotechnology feed | All feeds

Cordex Pharma, Inc.

Cordex Signs European Development Partnership for ATPotent(TM) Sperm Motility Drug

BioPortfolio no longer holds the full text of this article, it is however likley to be available via the below links:

Cordex Signs European Development Partnership for ATPotent(TM ... 22 Jun 2009 ... Cordex Signs European Development Partnership for ATPotent(TM) Sperm Motility Drug Technology Intended to Improve Outcome of Intrauterine ...
http://www.reuters.com/article/pressRelease/idUS97921+22-Jun...
ABC 7 - San Francisco Technology Intended to Improve Outcome of Intrauterine Insemination and In Vitro Fertilization Procedures LA JOLLA, Calif., June 22 /PRNewswire-FirstCall/ ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=KGOTRI.sto...
Archive News & Video for Monday, 22 Jun, 2009 | Reuters.com Cordex Signs European Development Partnership for ATPotent(TM) Sperm Motility Drug 08:15 AM EDT. World Golf Tour Offers the Home of Golf, St Andrews Links ...
http://www.reuters.com/resources/archive/us/20090622.html...

Browse other news from this organisation: Cordex Pharma, Inc.

(If any, Generated Automatically)

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.